Lavanchy D., 2009, Liver Int., 29, 74, 10.1111/j.1478-3231.2008.01934.x
Zeuzem S., 2009, J. Viral Hepatitus, 16, 75, 10.1111/j.1365-2893.2008.01012.x
Fried M. W., 2002, N. Engl. J. Med., 347, 975, 10.1056/NEJMoa020047
Burton J. R., 2009, Clin. Liver Dis., 13, 453, 10.1016/j.cld.2009.05.001
Beaulieu P. L., 2009, Expert Opin. Ther. Pat., 19, 145, 10.1517/13543770802672598
Simmonds P., 2004, J. Gen. Virol., 85, 3173, 10.1099/vir.0.80401-0
Le Guillou-Guillemette H., 2007, World J. Gastroenterol., 13, 2416, 10.3748/wjg.v13.i17.2416
Pierra C., 2006, J. Med. Chem., 49, 6614, 10.1021/jm0603623
Smith D. B., 2009, J. Med. Chem., 52, 2971, 10.1021/jm801595c
Clark J. L., 2005, J. Med. Chem., 48, 5504, 10.1021/jm0502788
Stuyver L. J., 2006, Antiviral Chem. Chemother., 17, 79, 10.1177/095632020601700203
Stuyver L. J., 2004, Antimicrob. Agents Chemother., 48, 651, 10.1128/AAC.48.2.651-654.2004
Reddy, R.; Rodriguez-Torres, M.; Gane, E.; Robson, R.; Lalezari, J.; Everson, G.; DeJesus, E.; McHutchinson, J.; Vargas, H.Presented at the 58th Annual Meeting of the American Association of the Study of Liver Disease, Boston, November 2007; Abstract LB9; unpublished results.
Lalezari, J.; Gane, E.; Rodriguez,Torres, M.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobson, I.; Reddy, R.; Hill, G. Z.; Beard, A.; Symonds, W. T.; Berrey, M. M.; McHutchison, J. G.Potent Antiviral Activity of the HCV Nucleoside Polymerase Inhibitor R7128 with PEG-INF and Ribavirin: Interim Results of R7128 500 mg BID for 28-Days. Presented at the 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, April 2008; unpublished results.
Rodriguez-Torres, M.; Lalezari, J; Gane, E.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobsen, I.; Reddy, R.; McHutchinson, J.; Beard, A.; Walker, S.; Symonds, B.; Berrey, M.Potent Antiviral Response to the HCV Nucleoside Polymerase Inhibitor R7128 for 28 Days with PEG-INF and Ribavirin: Subanalysis by Race/Ethnicity, Weight and HCV Genotype. Presented at the 59th Annual Meeting of the American Association for the Study of Liver Disease, San Francisco, CA, November 2008; Abstract No. 1899; unpublished results.
Ma H., 2007, J. Biol. Chem., 282, 29812, 10.1074/jbc.M705274200
Murakami E., 2007, Antimicrob. Agents Chemother., 51, 503, 10.1128/AAC.00400-06
Murakami E., 2008, Antimicrob. Agents Chemother., 52, 458, 10.1128/AAC.01184-07
McGuigan C., 1996, J. Med. Chem., 39, 1748, 10.1021/jm950605j
McGuigan C., 1998, Antiviral Chem. Chemother., 9, 473, 10.1177/095632029800900603
Saboulard D., 1999, Mol. Pharmacol., 56, 693
Perrone P., 2007, J. Med. Chem., 50, 55463
McGuigan C., 2009, Bioorg. Med. Chem. Lett., 19, 4250, 10.1016/j.bmcl.2009.05.099
Gardelli C., 2009, J. Med. Chem., 52, 5394, 10.1021/jm900447q
Wang P., 2009, J. Org. Chem., 74, 6819, 10.1021/jo901345j
Chen J., 2004, Cell Biol. Toxicol., 20, 183, 10.1023/B:CBTO.0000029468.89746.64
Phornchirasilp S., 1989, Biochem. Pharmacol., 38, 961, 10.1016/0006-2952(89)90287-6
Zhao F., 1995, Toxicol. Lett., 78, 35, 10.1016/0378-4274(95)99684-A
Niu C., 2008, Antiviral Ther., 13, 263, 10.1177/135965350801300206
Ghose A. K., 1998, J. Phys. Chem. A, 102, 3762, 10.1021/jp980230o
Faller B., 2008, Curr. Drug Metab., 9, 886, 10.2174/138920008786485227
Fleischer R. l., 2009, J. Hepatol., 51, 787, 10.1016/j.jhep.2009.06.011
Lewis W., 2003, Nat. Rev. Drug Discovery, 2, 812, 10.1038/nrd1201
Sammadossi J. P., 1987, Antimicrob. Agents Chemother., 31, 452, 10.1128/AAC.31.3.452
Sammadossi J. P., 1992, Biochem. Pharmacol., 44, 1921, 10.1016/0006-2952(92)90093-X
aSofia, M. J.; Du, J.; Wang, P.; Nagarathnam, D.Nucleoside Phosphoramidate Prodrugs. WO2008121634, 2008.
Migliaccio G., 2003, J. Biol. Chem., 278, 49164, 10.1074/jbc.M305041200
Le Pagam S., 2006, Virology, 351, 349, 10.1016/j.virol.2006.03.045
Ali S., 2008, Antimicrob. Agents Chemother., 52, 4356, 10.1128/AAC.00444-08
Altomare A., 1999, J. Appl. Crystallogr., 32, 115, 10.1107/S0021889898007717
Sheldrick G. M., 2008, Acta Crystallogr., 64, 112, 10.1107/S0108767307043930
Stuyver L. J., 2002, Antimicrob Agents Chemother., 46, 3854, 10.1128/AAC.46.12.3854-3860.2002
